Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 478.5	$ 802.1
Accounts receivable, less allowance for credit losses	1,404.9	1,452.7
Inventories	2,394.5	2,450.7
Prepaid taxes	329.5	208.8
Prepaid expenses and other current assets	277.6	169.0
Total Current Assets	4,885.0	5,083.3
Property, plant and equipment, net	2,016.5	2,047.7
Goodwill	9,192.2	9,261.8
Intangible assets, net	6,299.8	7,055.5
Other assets	1,062.9	969.4
Total Assets	23,456.4	24,417.7
Current Liabilities:
Accounts payable	351.2	330.0
Income taxes payable	65.1	59.5
Other current liabilities	1,446.5	1,667.4
Current portion of long-term debt	1,605.1	500.0
Total Current Liabilities	3,467.9	2,556.9
Deferred income taxes, net	665.6	790.4
Long-term income tax payable	583.2	588.1
Other long-term liabilities	609.6	656.4
Long-term debt	5,463.7	7,626.5
Total Liabilities	10,790.0	12,218.3
Commitments and Contingencies (Note 21)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 312.8 million (311.4 million in 2020) issued	3.1	3.1
Paid-in capital	9,314.8	9,121.6
Retained earnings	10,292.2	10,086.9
Accumulated other comprehensive loss	(231.6)	(297.8)
Treasury stock, 103.8 million shares (103.8 million shares in 2020)	(6,717.8)	(6,719.6)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,660.7	12,194.2
Noncontrolling interest	5.7	5.2
Total Stockholders' Equity	12,666.4	12,199.4
Total Liabilities and Stockholders' Equity	$ 23,456.4	$ 24,417.7